BASL School of Hepatology Meeting - Aston Business School, Birmingham
Friday, November 23, 2012 - Sunday, November 25, 2012
This is a two-day residential meeting. Free to all members with accommodation and catering provided by BASL.
Programme topics on Vascular Disorders, Portal Hypertension, Hepatocellular Carcinoma (HCC) and Liver Transplantation. Highlights include Renal dysfunction and ascites, Pathophysiology, Diagnosis and Managment if HRS. Hyponatraemia in Cirrhosis, Role of TIPSS, Varceal bleeding, Role of HCC screening and therapeutic options, and recipient selection and transplant assessment.
The day is designed to maximise interaction between the faculty and the delegates and will involve case discussions as well as lectures and formal presentations.
Please note that places for this event are limited and we advise those who are interested to contact us at the earliest opportunity.
To register please email email@example.com
Friday 23rd November 2012
17:30 onwards - Registration for early arrivals – sandwiches and refreshments available
Saturday 24th November 2012
08:30 Coffee and registration
09:00 Introduction and Welcome: Dr Dhiraj Tripathi, Consultant Hepatologist, Queen Elizabeth Hospital, Birmingham
09:10 Budd Chiari Syndrome: Dr Mervyn Davies, Consultant Hepatologist, St James University Hospital, Leeds
Learning aims: Diagnostic workup, role of interventional radiology.
09:40 Portal Vein Thrombosis: Dr Dhiraj Tripathi, Consultant Hepatologist, Queen Elizabeth Hospital, Birmingham
Learning aims: Pathophysiology, acute versus chronic PVT.
10:10 Case examples + interactive discussion
Learning aims: Timing of interventional radiology including TIPSS. Prognostic indicators, role of thrombolytic therapies and anticoagulation
Portal hypertension workshop
11:00 Renal dysfunction and ascites: Professor Kevin Moore, Consultant Hepatologist, Royal Free Hospital, London
11:30 Case examples + interactive discussion
Learning aims: Pathophysiology. Diagnosis and Management of HRS. Hyponatraemia in Cirrhosis. Latest Developments. Optimal use of terlipressin and albumin. Role of TIPSS.
12:00 Variceal bleeding: Professor Peter Hayes, Consultant Hepatologist, Royal Infirmary, Edinburgh
12:30 Case examples + interactive discussion
Learning aims: Acute bleeding and management. Prevention of rebleeding. TIPSS: selection criteria and timing. Role of antibiotics and terlipressin. Optimal endoscopic therapies
14:00 Non-cirrhotic portal hypertension: Professor Elwyn Elias, Professor of Hepatology, Birmingham
14:30 Case examples + interactive discussion
Learning Aims: Insights in to pathogenesis. Current and novel therapies. Management of patients with varices. Role of liver transplantation.
Hepatocellular Carcinoma: Update 2012
15:00 Role of HCC screening and therapeutic options: Dr Tahir Shah, Consultant Hepatologist, Queen Elizabeth Hospital, Birmingham
Learning aims: Patient selection and optimal screening methods. Treatment algorithms. Role of transplantation.
16:00 Treatment of HCC
a) What the radiologist can offer? Dr Kamarjit Mangat, Consultant Radiologist, Queen Elizabeth Hospital, Birmingham
Learning aims: Role of radiofrequency ablation. Patient selection and counselling. Latest developments.
b) HCC: What the oncologist can offer? Professor Daniel Palmer, Professor of Medical Oncology, University of Liverpool, Liverpool
Learning aims: Role of TACE, and multi kinase inhibitors. Latest trials
17:00 Case examples and interactive discussion
Sunday 25th November 2012
08:30 Recipient selection and transplant assessment: Dr Mark Hudson, Consultant Hepatologist, Freeman Hospital, Newcastle
09:00 Case examples and interactive discussion
Learning aims: Optimal timing for assessment. Psychological aspects e.g alcohol. Cardiopulmonary assessment.
09:30 A surgeon’s perspective for the physician: Mr Paolo Muiesan, Consultant Hepatobiliary and Liver Transplant Surgeon, Queen Elizabeth Hospital, Birmingham
10:00 Case examples and interactive discussion
Learning aims: Donor selection. Post operative complications. Impact of marginal grafts. Latest developments.
11:00 Renal dysfunction following liver transplantation: Professor James Neuberger, Consultant Hepatologist, Queen Elizabeth Hospital, Birmingham
11:30 Case examples and interactive discussion
Learning aims: Role of pre-operative renal function. Renal sparing strategies. Novel therapies and latest trials.
12:00 Disease recurrence following liver transplantation: Professor David Adams, Consultant Hepatologist, Queen Elizabeth Hospital, Birmingham
12:30 Case examples and interactive discussion
Learning aims: Factors predicting disease recurrence. Recurrent autoimmune and cholestatic diseases. Role of immunosuppression. Alcohol recidivism..